| Quantum-Si incorporated (QSI) Q1 2025 Earnings Call Transcript |
Quantum-Si incorporated (NASDAQ:QSI ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Scott Henry - Alliance Global Partners Swayampakula Ramakanth - HC Wainwright Operator Good afternoon, everyone and thank you for joining us. Earlier today, Quantum-Si released Financial Results for the First Quarter ended March 31, 2025. |
seekingalpha.com |
2025-05-16 00:24:15 |
Czytaj oryginał (ang.) |
| Quantum-Si Incorporated (QSI) Reports Q1 Loss, Lags Revenue Estimates |
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.14 per share a year ago. |
zacks.com |
2025-05-15 22:26:07 |
Czytaj oryginał (ang.) |
| Quantum-Si Reports First Quarter 2025 Financial Results |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports First Quarter 2025 Financial Results; Launches & Delivers First Platinum® Pro Units; Announces New Library Prep Development Program. |
businesswire.com |
2025-05-15 20:05:00 |
Czytaj oryginał (ang.) |
| Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage |
Despite beating EPS estimates in 3 of the last 4 quarters, post-earnings reactions have been mixed: +6.2% (Q4 beat), –22.0% (Q3 beat), and +3.7% (Q2 beat). |
247wallst.com |
2025-05-15 15:15:05 |
Czytaj oryginał (ang.) |
| Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). |
businesswire.com |
2025-05-13 20:05:00 |
Czytaj oryginał (ang.) |
| Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15 |
BRANFORD, Conn.--(BUSINESS WIRE)--Dr. Gloria Sheynkman, University of Virginia, Presents Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Nature Webinar on 5/15. |
businesswire.com |
2025-05-12 12:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025 |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025. |
businesswire.com |
2025-04-24 12:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™ |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™. |
businesswire.com |
2025-03-26 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to participate in DNAnexus webinar on large scale proteomics in multi-omics research. |
businesswire.com |
2025-03-24 08:01:00 |
Czytaj oryginał (ang.) |
| Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to participate in DNAnexus webinar on large scale proteomics in multi-omics research. |
businesswire.com |
2025-03-20 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). |
businesswire.com |
2025-03-13 18:05:00 |
Czytaj oryginał (ang.) |
| Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet |
Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting a significant improvement in performance will be needed to drive wider adoption. Quantum-Si believes that it can introduce a superior system in the next few years, but this involves significant uncertainty. |
seekingalpha.com |
2025-03-11 02:24:13 |
Czytaj oryginał (ang.) |
| Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript |
Quantum-Si incorporated (NASDAQ:QSI ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Katherine Atkins - SVP, Commercial Markets Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Douglas Mcpherson - H.C. Wainright Operator Thank you for standing by. |
seekingalpha.com |
2025-03-03 21:42:05 |
Czytaj oryginał (ang.) |
| Quantum-Si Incorporated (QSI) Reports Q4 Loss, Lags Revenue Estimates |
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.18 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.16 per share a year ago. |
zacks.com |
2025-03-03 20:35:24 |
Czytaj oryginał (ang.) |
| Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results. |
businesswire.com |
2025-03-03 18:05:00 |
Czytaj oryginał (ang.) |
| QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock? |
QSI's fourth-quarter performance is expected to have benefited from year-end capital spending and new product launches despite competition and stretched valuation. |
zacks.com |
2025-02-26 14:55:25 |
Czytaj oryginał (ang.) |
| Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025 |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025. |
businesswire.com |
2025-02-18 18:05:00 |
Czytaj oryginał (ang.) |
| Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument. |
businesswire.com |
2025-01-28 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK. |
businesswire.com |
2025-01-20 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). |
businesswire.com |
2025-01-17 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics. |
businesswire.com |
2025-01-13 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si's 327% Rally In Six Months: Is Nvidia The Catalyst For More Gains? |
Quantum-Si Inc. QSI is stealing the biotech spotlight with a jaw-dropping 327% surge over the past six months. The proteomics pioneer's stock now sits at $4.10, boasting a strong bullish trend and catching investors' attention. |
benzinga.com |
2025-01-07 11:30:51 |
Czytaj oryginał (ang.) |
| Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules. |
businesswire.com |
2025-01-03 18:06:00 |
Czytaj oryginał (ang.) |
| Quantum-Si: The Technical Picture Has Improved (Rating Upgrade) |
Since my last article, QSI's technical picture has improved, meeting all my investment criteria: bullish price action, momentum, volume, and relative strength. QSI is now above its upward sloping 30-week EMA, successfully retested a previous resistance level, and shows both short-term and long-term bullish momentum. Volume remains bullish, indicating institutional accumulation, and relative strength has improved significantly, outperforming the S&P 500. |
seekingalpha.com |
2024-12-29 11:30:00 |
Czytaj oryginał (ang.) |
| RGTI, QSI, QMCO, IONQ stocks are surging: time to short them? |
Quantum computing stocks have gone parabolic this month as investors pile into this sector, comparing it to the artificial intelligence industry. Rigetti Computing (RGTI) stock has soared by over 542% in the last 30 days, while Quantum-Si (QSI) has surged by 65% in the same period. |
invezz.com |
2024-12-27 05:11:28 |
Czytaj oryginał (ang.) |
| Quantum-Si's New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™ |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a new paper that was submitted to BioRxiv, demonstrating the capabilities of its proprietary bioinformatics tool called ProteoVue, for detecting and quantifying Single Amino Acid Variants (SAAVs). The paper, titled “Detecting Amino Acid Variants Using Next-Generation Protein Sequencing (NGPS),” highlights the transformative potential of. |
businesswire.com |
2024-12-20 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). |
businesswire.com |
2024-12-18 10:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Expands International Distribution Network |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Expands International Distribution Network. |
businesswire.com |
2024-12-12 07:00:00 |
Czytaj oryginał (ang.) |
| Are You Looking for a Top Momentum Pick? Why Quantum-Si Incorporated (QSI) is a Great Choice |
Does Quantum-Si Incorporated (QSI) have what it takes to be a top stock pick for momentum investors? Let's find out. |
zacks.com |
2024-12-11 15:01:16 |
Czytaj oryginał (ang.) |
| Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™ |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™. |
businesswire.com |
2024-12-04 10:30:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening. |
businesswire.com |
2024-12-03 10:30:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024. Quantum-Si's Management team announced Platinum™ Pro, the Company's evolution of Platinum, as well as Proteus™, the Company's new cutting-edge proteomics platform of the future, that is now under development. “We are very excited t. |
businesswire.com |
2024-11-21 08:00:00 |
Czytaj oryginał (ang.) |
| Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis |
On Wednesday, Quantum-Si Incorporated QSI stock traded over 100% higher after the protein sequencing company announced a collaboration with NVIDIA Corporation NVDA to develop its new proteomics platform, Proteus, and advance Quantum-Si's core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing. |
benzinga.com |
2024-11-20 12:14:08 |
Czytaj oryginał (ang.) |
| Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio, providing researchers across all market segments in t. |
businesswire.com |
2024-11-20 09:30:00 |
Czytaj oryginał (ang.) |
| Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si's core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing. This collaboration aims to significantly enhance data processing speeds to handle the increased data volume from Proteus. By leverag. |
businesswire.com |
2024-11-20 09:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform |
BRANFORD, Conn. & BLOOMINGTON, Minn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to support development of Proteus™, Quantum-Si's next-generation platform designed to transform proteomic research. The expanded collaboration will develop the consumable for Proteus that wil. |
businesswire.com |
2024-11-20 08:30:00 |
Czytaj oryginał (ang.) |
| Quantum-Si and Planet Innovation to Partner on Proteus™ |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will partner on the development and manufacturing of Quantum-Si's novel proteomics platform, Proteus™. Planet Innovation has a team of over four hundred people with expertise across design, development and manufacturing of scientific instrumentation and medical devices. Currently, Planet Innovation serves. |
businesswire.com |
2024-11-20 08:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 340,460 restricted stock units (“RSUs”) to a new employee under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the “2023 Inducement Plan”). The RSUs were granted as an inducement material to the new. |
businesswire.com |
2024-11-18 18:01:00 |
Czytaj oryginał (ang.) |
| Quantum-Si Honored with Frost & Sullivan's 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™ |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sullivan's prestigious 2024 Technology Innovation Leadership Award in North America. This award recognizes QSI's groundbreaking work in developing the Platinum® instrument, the first benchtop sequencer capable of providing single-molecule resolution at the amino acid level, opening new frontiers for. |
businesswire.com |
2024-11-13 08:00:00 |
Czytaj oryginał (ang.) |
| Quantum-Si incorporated (QSI) Q3 2024 Earnings Call Transcript |
Quantum-Si incorporated (NASDAQ:QSI ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Doug Farrell - VP, IR Jeffrey Hawkins - President & CEO Jeffry Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Operator Good day, and thank you for standing by. Welcome to the 2024 Third Quarter Quantum-Si Earnings Call. |
seekingalpha.com |
2024-11-12 19:48:09 |
Czytaj oryginał (ang.) |
| Quantum-Si Incorporated (QSI) Reports Q3 Loss, Lags Revenue Estimates |
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.15 per share a year ago. |
zacks.com |
2024-11-12 11:45:34 |
Czytaj oryginał (ang.) |
| Quantum-Si Reports Third Quarter 2024 Financial Results |
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of 2024 Announced that Liberate Bio has integrated Platinum® Next-Generation Sequencing into their platform for developing novel gene therapies with improved targeting capabilities Announced appoi. |
businesswire.com |
2024-11-12 09:30:00 |
Czytaj oryginał (ang.) |